SEC Form 4 · accession 0001225208-18-016009
Edwards Lifesciences Corp · EW
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Wesley W Von Schack
Director
Period of report
Nov 29, 2018
Accepted (ET)
Nov 30, 2018 · 4:07 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001099800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 29, 2018 | S | 1,319 | $160.9568 | D | 28,609 | I | The von Schack Revocable Trust |
| Common Stock | holding | — | — | — | 2,134 | D | ||
| Common StockF1 | holding | — | — | — | 10,000 | I | Wesley W von Schack Revocable Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes shares that were previously aggregated with other shares that were reported as held indirectly.
Remarks
This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.